YAP over-expression could inhibit nuclear localisation of both SRSF1 and YAP due to their binding with angiomotin, mitigating the inhibitory role of SRSF1 on Malat1 expression resulting in enhanced transwell migration of hepatocarcinoma cell lines as well as enhanced tumour growth of hepatocarcinoma cell lines in xenograft models [140]. This evidence concerns the gene SRSF1 and neoplasm.